PlainPharmaWatch

CMS Open Payments · Tool

Indivior Inc. vs Shoulder Innovations, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Indivior Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,598, versus 471 for the other company. Its single largest recorded recipient represents 0.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Indivior Inc.
HHI 1,598 · top recipient 0.4%
Ranked #841 of 1,838 companies by HHI
Shoulder Innovations, Inc.
HHI 471 · top recipient 0.1%
Ranked #1,309 of 1,838 companies by HHI

Payment Overview

Company A

Indivior Inc.

Total Payments
$8.6M
% of Industry
0.1%
Transactions
29,843
Avg per Transaction
$287.13
Recipients
27,311
Avg per Recipient
$313.75
Payment Types
6
Top Payment Type
Compensation for Services Other Than Consulting
Total Payments
$8.5M
% of Industry
0.1%
Transactions
1,002
Avg per Transaction
$8.5K
Recipients
991
Avg per Recipient
$8.6K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Indivior Inc. vs Shoulder Innovations, Inc. - total reported payments in CMS Open Payments PY2024

Indivior Inc.$8.6MShoulder Innovations, Inc.$8.5M

Payment Types Breakdown

Indivior Inc.

Compensation for Services Other Than Consulting $843.9K

9.8%

Food and Beverage $577.0K

6.7%

Consulting Fee $52.8K

0.6%

Travel and Lodging $23.6K

0.3%

Space Rental or Facility Fees $3.5K

0.0%

Education $523.44

0.0%

Shoulder Innovations, Inc.

Consulting Fee $962.1K

11.3%

Royalty or License $869.1K

10.2%

Travel and Lodging $279.4K

3.3%

Food and Beverage $44.2K

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Indivior Inc.

  1. 1

    DENVER HEALTH MEDICAL CENTER

    $584,026.75 · 9 txns

  2. 2

    BOSTON MEDICAL CENTER

    $129,995.65 · 18 txns

  3. 3

    BERKSHIRE MEDICAL CENTER

    $20,000.00 · 10 txns

  4. 4

    RAKESH AMIN

    $18,015.85 · 15 txns

  5. 5

    MEDICAL UNIVERSITY OF SOUTH CAROLINA

    $16,150.00 · 11 txns

Shoulder Innovations, Inc.

  1. 1

    ROBERT JAMES GILLESPIE

    $232,453.23 · 40 txns

  2. 2

    PETER SHAY JOHNSTON

    $216,406.03 · 25 txns

  3. 3

    STEPHEN BURKE GUNTHER

    $180,806.73 · 12 txns

  4. 4

    CHRISTOPHER ROBERT CHUINARD

    $157,838.32 · 22 txns

  5. 5

    GALEN S KAM

    $105,253.44 · 38 txns

Summary Comparison

Metric Indivior Inc. Shoulder Innovations, Inc.
Total Payments $8.6M $8.5M
% of Industry Total 0.1% 0.1%
Transaction Count 29,843 1,002
Avg per Transaction $287.13 $8.5K
Recipient Count 27,311 991
Avg per Recipient $313.75 $8.6K
Payment Type Count 6 4
Top Payment Type Compensation for Services Other Than Consulting Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.